PULMONARY BLASTOMYCOSIS

PULMONARY BLASTOMYCOSIS was reported 115 times

These drug classes are most commonly taken by patients reporting PULMONARY BLASTOMYCOSIS:

# Drug Count
0 Corticosteroid [EPC] 89
1 Calcineurin Inhibitor Immunosuppressant [EPC] 13
2 Nonsteroidal Anti-inflammatory Drug [EPC] 11
3 CD20-directed Cytolytic Antibody [EPC] 10
4 Proteasome Inhibitor [EPC] 10
5 Thalidomide Analog [EPC] 10
6 Alkylating Drug [EPC] 9
7 Nucleoside Metabolic Inhibitor [EPC] 8
8 Azole Antifungal [EPC] 7
9 Lipid-based Polyene Antifungal [EPC] 7
10 Polyene Antifungal [EPC] 7
11 Purine Antimetabolite [EPC] 7
12 Folate Analog Metabolic Inhibitor [EPC] 5
13 Antimetabolite Immunosuppressant [EPC] 3
14 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
15 Echinocandin Antifungal [EPC] 3
16 CD52-directed Cytolytic Antibody [EPC] 2
17 Immunoglobulin G [EPC] 2
18 Interleukin-12 Antagonist [EPC] 2
19 Interleukin-23 Antagonist [EPC] 2
20 Lipopeptide Antibacterial [EPC] 2
21 Tumor Necrosis Factor Blocker [EPC] 2
22 Benzodiazepine [EPC] 1
23 Bismuth [EPC] 1
24 Catecholamine [EPC] 1
25 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
26 Factor Xa Inhibitor [EPC] 1
27 Interleukin-4 Receptor alpha Antagonist [EPC] 1
28 Janus Kinase Inhibitor [EPC] 1
29 Kinase Inhibitor [EPC] 1
30 Macrolide Antimicrobial [EPC] 1
31 Opioid Agonist [EPC] 1
32 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1
33 Peroxisome Proliferator Receptor gamma Agonist [EPC] 1
34 Selective T Cell Costimulation Blocker [EPC] 1
35 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
36 Sulfonamide Antimicrobial [EPC] 1
37 Sulfonylurea [EPC] 1
38 Tetracycline-class Drug [EPC] 1
39 Thiazolidinedione [EPC] 1
40 mTOR Inhibitor Immunosuppressant [EPC] 1